Newcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi Post author:Sam Post published:January 31, 2018 Post category:BioPharma Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi. Source: BioSpace You Might Also Like Bristol-Myers Forks Over $40M Upfront for Another One of Ono Pharma's Cancer Prospects December 13, 2017 Eli Lilly Quietly Works on Wearable Devices in Lab Established in 2015 November 21, 2017 Ironwood Provides First Quarter 2017 Investor Update May 7, 2017
Bristol-Myers Forks Over $40M Upfront for Another One of Ono Pharma's Cancer Prospects December 13, 2017